Revenue for the quarter stood at ₹782 crore, up from ₹738 crore in Q1. EBITDA margins improved to 20.5%, up from 13.7% in the ...

One of⁠ the most effective​ ways for investors to grow thei‌r​ por​tf​olios⁠ is by harnessing the power of compounding ...

The troriluzole clinical development program encompassed the first industry clinical trials to generate data showing ...